Methods for detecting rapidly processed introns to evaluate allelic expression

1. A method for isolating and identifying allele-specific expression of a gene in a single cell, which method comprises: (a) providing a cell comprising a gene of interest, (b) expressing the gene of interest in the cell, (c) isolating one or more nascent RNA molecules transcribed from the gene of interest, (d) sequencing the one or more nascent RNA molecules isolated in (c), (e) determining the fragments per kilobase per millions (FPKM) for each exon and each intron present in the one or more nascent RNA molecules, (f) calculating an intron retention score (IRS) for each intron of the one or more nascent RNA molecules as follows: IRS = intron ⁢ ⁢ FPKM mean ⁢ ⁢ FPKM ⁢ ⁢ for ⁢ ⁢ two ⁢ ⁢ flanking ⁢ ⁢ exons , wherein the mean FPKM for two flanking exons is the mean FPKM for each exon contiguous with the intron, (g) ranking each intron of the one or more nascent RNA molecules according to the intron retention score for each intron and identifying rapidly processed introns, wherein an intron retention score less than or equal to 0.018 identifies an intron as being rapidly processed, and an intron retention score greater than 0.018 identifies an intron as not being rapidly processed, (h) designing one or more nucleic acid probes that specifically bind to an intron identified by steps (a)-(g) as being rapidly processed, wherein the one or more probes comprise a detectable label, (i) conducting RNA in situ hybridization on the rapidly processed intron using the one or more probes, and (j) analyzing a signal produced by the detectable label, wherein the presence of one signal indicates that the gene of interest is expressed from one allele and the presence of two signals indicates that the gene of interest is expressed from two alleles.

2. The method of claim 1 , wherein the one or more nascent RNA molecules is in the process of posttranscriptional processing and is messenger RNA (mRNA).

3. The method of claim 2 , wherein the mRNA is polyadenylated mRNA.

4. The method of claim 1 , further comprising comparing the signal produced by the detectable label to an internal control gene that exhibits biallelic expression.